An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.

Shi JR, Poulard C, Cerutti C, Trédan O, Le Romancer M, Shi TL, Vanacker JM

Open source

DOI
10.1186/s10020-026-01487-4
Published
2026 May 8
Container
Molecular medicine (Cambridge, Mass.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s10020-026-01487-4,
  title = {An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.},
  author = {Shi JR and Poulard C and Cerutti C and Trédan O and Le Romancer M and Shi TL and Vanacker JM},
  year = {2026},
  journal = {Molecular medicine (Cambridge, Mass.)},
  doi = {10.1186/s10020-026-01487-4},
  url = {https://doi.org/10.1186/s10020-026-01487-4}
}

RIS

TY  - JOUR
TI  - An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.
AU  - Shi JR
AU  - Poulard C
AU  - Cerutti C
AU  - Trédan O
AU  - Le Romancer M
AU  - Shi TL
AU  - Vanacker JM
PY  - 2026
JO  - Molecular medicine (Cambridge, Mass.)
DO  - 10.1186/s10020-026-01487-4
UR  - https://doi.org/10.1186/s10020-026-01487-4
ER  - 

APA

JR, S., C, P., C, C., O, T., M, L. R., TL, S., & JM, V. (2026). An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01487-4

Source records